EUVIMEDEUVIMED entdecken
ValidierungsstudieDelphi-Studie

Older adult risk classification for anticholinergics (ORCA): a Delphi panel-validated scale

Ine Simal iD, Annemie Somers iD, Jesper Ryg iD, Eveline Poelgeest iD, Nathalie van der Velde iD, Sirpa Hartikainen iD, Yvonne Morrissey, Tomas J Welsh iD, Alpana Mair iD, Tahir Masud iD, Marta Gutiérrez-Valencia iD, Gulistan Bahat iD und 5 weitere

Age and Ageing · 2025

DOI: 10.1093/ageing/afaf313 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Age and Ageing, 2025. Verfasst von Ine Simal und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University Hospital Ghent, Ghent, Belgium. Hauptthemen laut MEDLINE: Cholinergic Antagonists, Delphi Technique, Decision Support Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drugs with anticholinergic properties (DAP) are widely prescribed in older adults for various medical conditions. However, their cumulative anticholinergic burden is associated with adverse outcomes, including cognitive decline, falls and hospitalisations. Anticholinergic scales vary significantly, complicating their interpretation and application into clinical practice and research. Recent systematic reviews provide an overview of existing scales, however often lack the clinical perspective of healthcare professionals. To address this gap, we developed the older adult risk classification for anticholinergics (ORCA) scale, incorporating both evidence and expert clinical judgement.

Methods

A preliminary drug list was derived from the most comprehensive systematic review. A two-round Delphi process was conducted with 14 clinicians from nine European countries with substantial expertise in geriatric medicines and clinical pharmacology. Each round consisted of two phases in which experts rated the anticholinergic burden of drugs using a four-point Likert scale. Additional drugs and anticholinergic burden scales could be proposed at any point. Consensus was defined using the Lynn method.

Results

A total of 233 drugs were assessed. Experts classified 17 drugs as having no anticholinergic properties, 115 as low, 31 as moderate and 65 as high burden. The majority of included DAP were central nervous system drugs, particularly antipsychotics and antidepressants. Five drugs did not reach consensus.

Conclusion

The ORCA scale is a clinically informed, evidence-based classification of DAP tailored for older adults. It offers a standardised tool to support clinicians, pharmacists and researchers in assessing anticholinergic burden, enhancing prescribing safety and guiding therapeutic decision-making in this vulnerable population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinergic AntagonistsDelphi TechniqueDecision Support TechniquesHumansRisk AssessmentAgedConsensusRisk FactorsAge FactorsReproducibility of ResultsMaleEurope

Stichwörter der Autor:innen

Delphi panelanticholinergic scaleanticholinergicsolder adults

Substanzen

Cholinergic Antagonists

Autor:innen und Institutionen

  • Department of Pharmacy, University Hospital Ghent, Ghent, Belgium.
  • Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
  • Faculty of Pharmaceutical Sciences - Pharmaceutical Care Unit, Ghent University, Ghent, Belgium.
  • Geriatric Research Unit, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Internal Medicine Geriatric Section, Herlev and Gentofte, Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Ine Simal, Annemie Somers, Jesper Ryg, Eveline Poelgeest, Nathalie van der Velde, Sirpa Hartikainen, Tomas J Welsh, Alpana Mair, Tahir Masud, Marta Gutiérrez-Valencia, Gulistan Bahat, Birkan Ilhan, Maria Á Caballero Mora, Francesco Landi, Andreas Capiau, Mirko Petrovic

Zitieren

APA

Simal, I., Somers, A., Ryg, J., Poelgeest, E., van der Velde, N., Hartikainen, S., Morrissey, Y., Welsh, T. J., Mair, A., Masud, T., Gutiérrez-Valencia, M., Bahat, G., Ilhan, B., Caballero Mora, M. Á., Landi, F., Capiau, A., & Petrovic, M. (2025). Older adult risk classification for anticholinergics (ORCA): a Delphi panel-validated scale. Age and Ageing. https://doi.org/10.1093/ageing/afaf313

Vancouver

Simal I, Somers A, Ryg J, Poelgeest E, van der Velde N, Hartikainen S, et al. Older adult risk classification for anticholinergics (ORCA): a Delphi panel-validated scale. Age and Ageing. 2025. doi:10.1093/ageing/afaf313

BibTeX
@article{Simal2025,
  author = {Simal, Ine and Somers, Annemie and Ryg, Jesper and Poelgeest, Eveline and van der Velde, Nathalie and Hartikainen, Sirpa and Morrissey, Yvonne and Welsh, Tomas J and Mair, Alpana and Masud, Tahir and Gutiérrez-Valencia, Marta and Bahat, Gulistan and Ilhan, Birkan and Caballero Mora, Maria Á and Landi, Francesco and Capiau, Andreas and Petrovic, Mirko},
  title = {Older adult risk classification for anticholinergics (ORCA): a Delphi panel-validated scale},
  journal = {Age and Ageing},
  year = {2025},
  doi = {10.1093/ageing/afaf313}
}
Kostenlos starten →